Skip to main content
Erschienen in: Journal of Community Health 6/2012

01.12.2012 | Original Paper

Ohio Appalachia Public Health Department Personnel: Human Papillomavirus (HPV) Vaccine Availability, and Acceptance and Concerns Among Parents of Male and Female Adolescents

verfasst von: Benjamin R. Oldach, Mira L. Katz

Erschienen in: Journal of Community Health | Ausgabe 6/2012

Einloggen, um Zugang zu erhalten

Abstract

Public health departments (n = 48) serving the 32 counties of Ohio Appalachia were contacted to determine human papillomavirus (HPV) vaccine availability and to assess patient and parental attitudes, perceived barriers, and decisional differences about vaccination for male and female adolescents. Nurses or nursing supervisors in 46 of 48 health departments agreed to participate with 45 (97.8 %) reporting that HPV vaccines were available for males and females. HPV vaccination barriers reported most frequently were lack of knowledge about the vaccines, concerns about potential side effects, the newness of the HPV vaccines, and parents believing their children were not sexually active or were too young to receive an HPV vaccine. Provider reports of the primary differences in the acceptability of an HPV vaccine among parents of males compared to the parents of females were lack of awareness that an HPV vaccine was available for males, not understanding why the vaccine should be given to males, and fear of vaccination increasing sexual promiscuity among female adolescents. Half of the health departments (n = 24) reported that parents of females were more receptive toward HPV vaccination, 16 health departments reported no difference in acceptability based on gender of the child, and 5 health departments reported that parents of males were more receptive. This study suggests that there are different informational needs of males and females and parents of male and female children when making an informed decision about HPV vaccination. Findings highlight content to include in strategies to increase HPV vaccination rates among Appalachia Ohio residents.
Literatur
1.
Zurück zum Zitat Hariri, S., Unger, E. R., Sternberg, M., et al. (2011). Prevalence of genital human papillomavirus among females in the United States, the National Health and Nutrition Examination Survey, 2003–2006. Journal of Infectious, 204(4), 566–573.CrossRef Hariri, S., Unger, E. R., Sternberg, M., et al. (2011). Prevalence of genital human papillomavirus among females in the United States, the National Health and Nutrition Examination Survey, 2003–2006. Journal of Infectious, 204(4), 566–573.CrossRef
2.
Zurück zum Zitat Nyitray, A. G., da Silva, R. J., Baggio, M. L., et al. (2011). The prevalence of genital HPV and factors associated with oncogenic HPV among men having sex with men and men having sex with women and men: The HIM study. Sexually Transmitted Diseases, 38(10), 932–940.PubMedCrossRef Nyitray, A. G., da Silva, R. J., Baggio, M. L., et al. (2011). The prevalence of genital HPV and factors associated with oncogenic HPV among men having sex with men and men having sex with women and men: The HIM study. Sexually Transmitted Diseases, 38(10), 932–940.PubMedCrossRef
3.
Zurück zum Zitat Walboomers, J. M., Jacobs, M. V., Manos, M. M., et al. (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. Journal of Pathology, 189(1), 12–19.PubMedCrossRef Walboomers, J. M., Jacobs, M. V., Manos, M. M., et al. (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. Journal of Pathology, 189(1), 12–19.PubMedCrossRef
4.
Zurück zum Zitat Munoz, N., Castellsague, X., de Gonzalez, A. B., & Gissmann, L. (2006). Chapter 1: HPV in the etiology of human cancer. Vaccine, 24(Suppl 3), S3/1–S3/10. Munoz, N., Castellsague, X., de Gonzalez, A. B., & Gissmann, L. (2006). Chapter 1: HPV in the etiology of human cancer. Vaccine, 24(Suppl 3), S3/1–S3/10.
5.
Zurück zum Zitat Lacey, C. J., Lowndes, C. M., & Shah, K. V. (2006). Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease. Vaccine, 24(Suppl 3), 35–41.CrossRef Lacey, C. J., Lowndes, C. M., & Shah, K. V. (2006). Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease. Vaccine, 24(Suppl 3), 35–41.CrossRef
6.
Zurück zum Zitat Gillison, M. L., Chaturvedi, A. K., & Lowy, D. R. (2008). HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer, 113(10 Suppl), 3036–3046.PubMedCrossRef Gillison, M. L., Chaturvedi, A. K., & Lowy, D. R. (2008). HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer, 113(10 Suppl), 3036–3046.PubMedCrossRef
7.
Zurück zum Zitat Huang, B., Wyatt, S. W., Tucker, T. C., Bottorff, D., Lengerich, E., & Hall, H. I. (2002). Cancer death rates–Appalachia, 1994–1998. MMWR: Morbidity and Mortality Weekly Report, 51(24), 527–529. Huang, B., Wyatt, S. W., Tucker, T. C., Bottorff, D., Lengerich, E., & Hall, H. I. (2002). Cancer death rates–Appalachia, 1994–1998. MMWR: Morbidity and Mortality Weekly Report, 51(24), 527–529.
8.
Zurück zum Zitat Hopenhayn, C., Bush, H., Christian, A., & Shelton, B. J. (2005). Comparative analysis of invasive cervical cancer incidence rates in three Appalachian states. Preventative Medicine, 41(5–6), 859–864.CrossRef Hopenhayn, C., Bush, H., Christian, A., & Shelton, B. J. (2005). Comparative analysis of invasive cervical cancer incidence rates in three Appalachian states. Preventative Medicine, 41(5–6), 859–864.CrossRef
9.
Zurück zum Zitat Lengerich, E. J., Tucker, T. C., Powell, R. K., et al. (2005). Cancer incidence in Kentucky, Pennsylvania, and West Virginia: Disparities in Appalachia. Journal of Rural Health, 21(1), 39–47.PubMedCrossRef Lengerich, E. J., Tucker, T. C., Powell, R. K., et al. (2005). Cancer incidence in Kentucky, Pennsylvania, and West Virginia: Disparities in Appalachia. Journal of Rural Health, 21(1), 39–47.PubMedCrossRef
10.
Zurück zum Zitat Hopenhayn, C., King, J. B., Christian, A., Huang, B., & Christian, W. J. (2008). Variability of cervical cancer rates across 5 Appalachian states, 1998–2003. Cancer, 113(10 Suppl), 2974–2980.PubMedCrossRef Hopenhayn, C., King, J. B., Christian, A., Huang, B., & Christian, W. J. (2008). Variability of cervical cancer rates across 5 Appalachian states, 1998–2003. Cancer, 113(10 Suppl), 2974–2980.PubMedCrossRef
11.
Zurück zum Zitat Wingo, P. A., Tucker, T. C., Jamison, P. M., et al. (2008). Cancer in Appalachia, 2001–2003. Cancer, 112(1), 181–192.PubMedCrossRef Wingo, P. A., Tucker, T. C., Jamison, P. M., et al. (2008). Cancer in Appalachia, 2001–2003. Cancer, 112(1), 181–192.PubMedCrossRef
12.
Zurück zum Zitat Marmot, M., & Wilkinson, R. G. (2005). Social determinants of health. New York, NY: Oxford University Press.CrossRef Marmot, M., & Wilkinson, R. G. (2005). Social determinants of health. New York, NY: Oxford University Press.CrossRef
13.
Zurück zum Zitat Warnecke, R. B., Oh, A., Breen, N., et al. (2008). Approaching health disparities from a population perspective: The National Institutes of Health Centers for Population Health and Health Disparities. American Journal of Public Health, 98(9), 1608–1615.PubMedCrossRef Warnecke, R. B., Oh, A., Breen, N., et al. (2008). Approaching health disparities from a population perspective: The National Institutes of Health Centers for Population Health and Health Disparities. American Journal of Public Health, 98(9), 1608–1615.PubMedCrossRef
14.
Zurück zum Zitat Wewers, M. E., Katz, M., Fickle, D., & Paskett, E. D. (2006). Risky behaviors among Ohio Appalachian adults. Preventing Chronic Disease, 3(4), A127.PubMed Wewers, M. E., Katz, M., Fickle, D., & Paskett, E. D. (2006). Risky behaviors among Ohio Appalachian adults. Preventing Chronic Disease, 3(4), A127.PubMed
15.
Zurück zum Zitat Yabroff, K. R., Lawrence, W. F., King, J. C., et al. (2005). Geographic disparities in cervical cancer mortality: What are the roles of risk factor prevalence, screening, and use of recommended treatment? Journal of Rural Health, 21(2), 149–157.PubMedCrossRef Yabroff, K. R., Lawrence, W. F., King, J. C., et al. (2005). Geographic disparities in cervical cancer mortality: What are the roles of risk factor prevalence, screening, and use of recommended treatment? Journal of Rural Health, 21(2), 149–157.PubMedCrossRef
16.
Zurück zum Zitat Katz, M. L., Wewers, M. E., Single, N., & Paskett, E. D. (2007). Key informants’ perspectives prior to beginning a cervical cancer study in Ohio Appalachia. Qualitative Health Research, 17(1), 131–141.PubMedCrossRef Katz, M. L., Wewers, M. E., Single, N., & Paskett, E. D. (2007). Key informants’ perspectives prior to beginning a cervical cancer study in Ohio Appalachia. Qualitative Health Research, 17(1), 131–141.PubMedCrossRef
17.
Zurück zum Zitat Schoenberg, N. E., Hopenhayn, C., Christian, A., Knight, E. A., & Rubio, A. (2005). An in-depth and updated perspective on determinants of cervical cancer screening among central Appalachian women. Journal of Women’s Health, 42(2), 89–105. Schoenberg, N. E., Hopenhayn, C., Christian, A., Knight, E. A., & Rubio, A. (2005). An in-depth and updated perspective on determinants of cervical cancer screening among central Appalachian women. Journal of Women’s Health, 42(2), 89–105.
18.
Zurück zum Zitat Lyttle, N. L., & Stadelman, K. (2006). Assessing awareness and knowledge of breast and cervical cancer among Appalachian women. Preventing Chronic Disease, 3(4), A125.PubMed Lyttle, N. L., & Stadelman, K. (2006). Assessing awareness and knowledge of breast and cervical cancer among Appalachian women. Preventing Chronic Disease, 3(4), A125.PubMed
19.
Zurück zum Zitat Markowitz, L. E., Dunne, E. F., Saraiya, M., Lawson, H. W., Chesson, H., & Unger, E. R. (2007). Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR: Recommendations and Reports, 56(RR-2), 1–24.PubMed Markowitz, L. E., Dunne, E. F., Saraiya, M., Lawson, H. W., Chesson, H., & Unger, E. R. (2007). Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR: Recommendations and Reports, 56(RR-2), 1–24.PubMed
20.
Zurück zum Zitat Centers for Disease Control and Prevention. (2010). FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR: Morbidity and Mortality Weekly Report, 59(20), 626–629. Centers for Disease Control and Prevention. (2010). FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR: Morbidity and Mortality Weekly Report, 59(20), 626–629.
21.
Zurück zum Zitat Centers for Disease Control and Prevention. (2010). FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP). MMWR: Morbidity and Mortality Weekly Report, 59(20), 630–632. Centers for Disease Control and Prevention. (2010). FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP). MMWR: Morbidity and Mortality Weekly Report, 59(20), 630–632.
22.
Zurück zum Zitat Usher, W. T. (2012). Australian health professionals’ social media (Web 2.0) adoption trends: Early 21st century health care delivery and practice promotion. Australian Journal of Primary Health, 18(1), 31–41.PubMedCrossRef Usher, W. T. (2012). Australian health professionals’ social media (Web 2.0) adoption trends: Early 21st century health care delivery and practice promotion. Australian Journal of Primary Health, 18(1), 31–41.PubMedCrossRef
23.
Zurück zum Zitat Centers for Disease Control and Prevention. (2011). Recommendations on the use of quadrivalent human papillomavirus vaccine in males—Advisory Committee on Immunization Practices (ACIP). MMWR: Morbidity and Mortality Weekly Report, 60(50), 1705–1708. Centers for Disease Control and Prevention. (2011). Recommendations on the use of quadrivalent human papillomavirus vaccine in males—Advisory Committee on Immunization Practices (ACIP). MMWR: Morbidity and Mortality Weekly Report, 60(50), 1705–1708.
24.
Zurück zum Zitat Dorell, C., Stokley, S., Yankey, D., Liang, J., & Markowitz, L. (2010). National and state vaccination coverage among adolescents aged 13 through 17 years—United States. MMWR: Morbidity and Mortality Weekly Report, 60(33), 1117–1123. Dorell, C., Stokley, S., Yankey, D., Liang, J., & Markowitz, L. (2010). National and state vaccination coverage among adolescents aged 13 through 17 years—United States. MMWR: Morbidity and Mortality Weekly Report, 60(33), 1117–1123.
25.
Zurück zum Zitat Reiter, P. L., McRee, A. L., Kadis, J. A., & Brewer, N. T. (2011). HPV vaccine and adolescent males. Vaccine, 29(34), 5595–5602.PubMedCrossRef Reiter, P. L., McRee, A. L., Kadis, J. A., & Brewer, N. T. (2011). HPV vaccine and adolescent males. Vaccine, 29(34), 5595–5602.PubMedCrossRef
26.
Zurück zum Zitat Abramson, R., & Haskell, J. (2006). Encyclopedia of Appalachia. Knoxville, TN: University of Tennessee Press. Abramson, R., & Haskell, J. (2006). Encyclopedia of Appalachia. Knoxville, TN: University of Tennessee Press.
27.
Zurück zum Zitat Campos-Outcalt, D., Jeffcott-Pera, M., Carter-Smith, P., Schoof, B. K., & Young, H. F. (2010). Vaccines provided by family physicians. The Annals of Family Medicine, 8(6), 507–510.CrossRef Campos-Outcalt, D., Jeffcott-Pera, M., Carter-Smith, P., Schoof, B. K., & Young, H. F. (2010). Vaccines provided by family physicians. The Annals of Family Medicine, 8(6), 507–510.CrossRef
28.
Zurück zum Zitat Katz, M. L., Reiter, P. L., Kluhsman, B. C., et al. (2009). Human papillomavirus (HPV) vaccine availability, recommendations, cost, and policies among health departments in seven Appalachian states. Vaccine, 27(24), 3195–3200.PubMedCrossRef Katz, M. L., Reiter, P. L., Kluhsman, B. C., et al. (2009). Human papillomavirus (HPV) vaccine availability, recommendations, cost, and policies among health departments in seven Appalachian states. Vaccine, 27(24), 3195–3200.PubMedCrossRef
29.
Zurück zum Zitat Omurtag, K., Jimenez, P. T., Ratts, V., Odem, R., & Cooper, A. R. (2012). The ART of social networking: How SART member clinics are connecting with patients online. Fertility and Sterility, 97(1), 88–94.PubMedCrossRef Omurtag, K., Jimenez, P. T., Ratts, V., Odem, R., & Cooper, A. R. (2012). The ART of social networking: How SART member clinics are connecting with patients online. Fertility and Sterility, 97(1), 88–94.PubMedCrossRef
31.
Zurück zum Zitat Miles, M. B., & Huberman, A. M. (1994). Qualitative data analysis: An expanded sourcebook. Thousand Oaks, CA: Sage Publications. Miles, M. B., & Huberman, A. M. (1994). Qualitative data analysis: An expanded sourcebook. Thousand Oaks, CA: Sage Publications.
33.
Zurück zum Zitat Vadaparampil, S. T., Kahn, J. A., Salmon, D., et al. (2011). Missed clinical opportunities: Provider recommendations for HPV vaccination for 11–12 year old girls are limited. Vaccine, 29(47), 8634–8641.PubMedCrossRef Vadaparampil, S. T., Kahn, J. A., Salmon, D., et al. (2011). Missed clinical opportunities: Provider recommendations for HPV vaccination for 11–12 year old girls are limited. Vaccine, 29(47), 8634–8641.PubMedCrossRef
34.
Zurück zum Zitat Daley, E. M., Vamos, C. A., Buhi, E. R., et al. (2010). Influences on human papillomavirus vaccination status among female college students. Journal of Women’s Health, 19(10), 1885–1891.PubMedCrossRef Daley, E. M., Vamos, C. A., Buhi, E. R., et al. (2010). Influences on human papillomavirus vaccination status among female college students. Journal of Women’s Health, 19(10), 1885–1891.PubMedCrossRef
35.
Zurück zum Zitat Conroy, K., Rosenthal, S. L., Zimet, G. D., et al. (2009). Human papillomavirus vaccine uptake, predictors of vaccination, and self-reported barriers to vaccination. Journal of Women’s Health, 18(10), 1679–1686.PubMedCrossRef Conroy, K., Rosenthal, S. L., Zimet, G. D., et al. (2009). Human papillomavirus vaccine uptake, predictors of vaccination, and self-reported barriers to vaccination. Journal of Women’s Health, 18(10), 1679–1686.PubMedCrossRef
36.
Zurück zum Zitat Fernandez, M. E., Allen, J. D., Mistry, R., & Kahn, J. A. (2010). Integrating clinical, community, and policy perspectives on human papillomavirus vaccination. Annual Review of Public Health, 31, 235–252.PubMedCrossRef Fernandez, M. E., Allen, J. D., Mistry, R., & Kahn, J. A. (2010). Integrating clinical, community, and policy perspectives on human papillomavirus vaccination. Annual Review of Public Health, 31, 235–252.PubMedCrossRef
37.
Zurück zum Zitat Zimet, G. D., Weiss, T. W., Rosenthal, S. L., Good, M. B., & Vichnin, M. D. (2010). Reasons for non-vaccination against HPV and future vaccination intentions among 19–26 year-old women. BMC Women’s Health, 10, 27.PubMed Zimet, G. D., Weiss, T. W., Rosenthal, S. L., Good, M. B., & Vichnin, M. D. (2010). Reasons for non-vaccination against HPV and future vaccination intentions among 19–26 year-old women. BMC Women’s Health, 10, 27.PubMed
38.
Zurück zum Zitat Ford, C. A., English, A., Davenport, A. F., & Stinnett, A. J. (2009). Increasing adolescent vaccination: Barriers and strategies in the context of policy, legal, and financial issues. Journal of Adolescent Health, 44(6), 568–574.PubMedCrossRef Ford, C. A., English, A., Davenport, A. F., & Stinnett, A. J. (2009). Increasing adolescent vaccination: Barriers and strategies in the context of policy, legal, and financial issues. Journal of Adolescent Health, 44(6), 568–574.PubMedCrossRef
39.
Zurück zum Zitat Jain, N., Euler, G. L., Shefer, A., Lu, P., Yankey, D., & Markowitz, L. (2009). Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, National Immunization Survey-Adult 2007. Preventive Medicine, 48(5), 426–431.PubMedCrossRef Jain, N., Euler, G. L., Shefer, A., Lu, P., Yankey, D., & Markowitz, L. (2009). Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, National Immunization Survey-Adult 2007. Preventive Medicine, 48(5), 426–431.PubMedCrossRef
40.
Zurück zum Zitat Caskey, R., Lindau, S. T., & Alexander, G. C. (2009). Knowledge and early adoption of the HPV vaccine among girls and young women: Results of a national survey. Journal of Adolescent Health, 45(5), 453–462.PubMedCrossRef Caskey, R., Lindau, S. T., & Alexander, G. C. (2009). Knowledge and early adoption of the HPV vaccine among girls and young women: Results of a national survey. Journal of Adolescent Health, 45(5), 453–462.PubMedCrossRef
41.
Zurück zum Zitat Reiter, P. L., Brewer, N. T., & Smith, J. S. (2010). Human papillomavirus knowledge and vaccine acceptability among a national sample of heterosexual men. Sexually Transmitted Infections, 86(3), 241–246.PubMedCrossRef Reiter, P. L., Brewer, N. T., & Smith, J. S. (2010). Human papillomavirus knowledge and vaccine acceptability among a national sample of heterosexual men. Sexually Transmitted Infections, 86(3), 241–246.PubMedCrossRef
42.
Zurück zum Zitat Zimet, G. D., & Rosenthal, S. L. (2010). HPV vaccine and males: Issues and challenges. Gynecologic Oncology, 117(2 Suppl), S26–S31.PubMedCrossRef Zimet, G. D., & Rosenthal, S. L. (2010). HPV vaccine and males: Issues and challenges. Gynecologic Oncology, 117(2 Suppl), S26–S31.PubMedCrossRef
43.
Zurück zum Zitat Katz, M. L., Krieger, J. L., & Roberto, A. J. (2011). Human papillomavirus (HPV): College male’s knowledge, perceived risk, sources of information, vaccine barriers and communication. Journal of Men’s Health, 8(3), 175–184.PubMedCrossRef Katz, M. L., Krieger, J. L., & Roberto, A. J. (2011). Human papillomavirus (HPV): College male’s knowledge, perceived risk, sources of information, vaccine barriers and communication. Journal of Men’s Health, 8(3), 175–184.PubMedCrossRef
44.
Zurück zum Zitat Berenson, A. B., & Rahman, M. (2012). Gender differences among low income women in their intent to vaccinate their sons and daughters against human papillomavirus infection. Journal of Pediatric and Adolescent Gynecology, 25(3), 218–220.PubMedCrossRef Berenson, A. B., & Rahman, M. (2012). Gender differences among low income women in their intent to vaccinate their sons and daughters against human papillomavirus infection. Journal of Pediatric and Adolescent Gynecology, 25(3), 218–220.PubMedCrossRef
Metadaten
Titel
Ohio Appalachia Public Health Department Personnel: Human Papillomavirus (HPV) Vaccine Availability, and Acceptance and Concerns Among Parents of Male and Female Adolescents
verfasst von
Benjamin R. Oldach
Mira L. Katz
Publikationsdatum
01.12.2012
Verlag
Springer US
Erschienen in
Journal of Community Health / Ausgabe 6/2012
Print ISSN: 0094-5145
Elektronische ISSN: 1573-3610
DOI
https://doi.org/10.1007/s10900-012-9613-5

Weitere Artikel der Ausgabe 6/2012

Journal of Community Health 6/2012 Zur Ausgabe